A Pan-European, open label, randomised study comparing the efficacy and cost-effectiveness of Symbicort® Maintenance And Reliever Therapy (Symbicort® SMART) using a maintenance dose of Symbicort® 160/4.5μg of 1 or 2 inhalations twice daily in the treatment of persistent asthma